Skip to main content
DreamCIS INC. logo

DreamCIS INC. — Investor Relations & Filings

Ticker · 223250 ISIN · KR7223250002 KO Professional, scientific and technical activities
Open in API
Filings indexed 200 across all filing types
Latest filing 2022-04-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 223250

About DreamCIS INC.

https://dreamcis.com/

DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Capital Increase Decision' (유상증자결정) and a subsequent 'Correction Report' (정정신고). This filing details the issuance of new shares, the purpose of the capital raise, and the specific terms of the third-party allocation. In the context of financial filings, announcements regarding the issuance of new shares, stock splits, or capital structure changes are classified as 'Share Issue/Capital Change'.
2022-04-22 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the issuance of new shares, the purpose of the capital increase, the third-party allocation details, and includes a correction notice (정정신고) for the listing date. This falls under the category of announcements regarding new share issues and capital changes.
2022-04-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including the identity of the major shareholder (HONGKONG TIGERMED CO.,LTD), changes in special relationships (director resignations and appointments), and specific shareholding percentages. This type of filing is a mandatory disclosure for significant changes in share ownership and does not fit into categories like Annual Reports, Earnings Releases, or Proxy Statements. Therefore, it is classified as a Major Shareholding Notification.
2022-04-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). It details the share ownership and changes in holdings for a specific executive (Jeounghee Yoo) of DreamCIS. This type of filing is a standard regulatory disclosure for insider holdings, which falls under the 'Director's Dealing' category.
2022-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for DreamCIS, dated 2022-03-30. It details the approval of financial statements, dividend resolutions, and the election of board members and auditors. This type of filing is specifically categorized as a Declaration of Voting Results & Voting Rights Announcement (DVA) in the provided schema, as it reports the outcome of shareholder votes at an AGM.
2022-03-30 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's Representative Director (CEO). It details the outgoing director, the incoming director (Yoo Jung-hee), the reason for the change (new appointment), and the date of the board resolution. This falls directly under the category of board/management changes.
2022-03-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.